These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2440320)

  • 1. Mediation of "calcium antagonist" effects by dopamine receptor blockade.
    Nurnberger J; Simmons-Alling S
    Am J Psychiatry; 1987 Jul; 144(7):966-7. PubMed ID: 2440320
    [No Abstract]   [Full Text] [Related]  

  • 2. How does verapamil exert an antimanic effect?
    Sandyk R; Gillman MA
    Am J Psychiatry; 1986 Mar; 143(3):388. PubMed ID: 2420217
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of verapamil and diltiazem on N-, P- and Q-type calcium channels mediating dopamine release in rat striatum.
    Dobrev D; Milde AS; Andreas K; Ravens U
    Br J Pharmacol; 1999 May; 127(2):576-82. PubMed ID: 10385261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of verapamil, diltiazem and ryosidine on the release of dopamine and acetylcholine in rabbit caudate nucleus slices.
    Starke K; Späth L; Wichmann T
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):124-30. PubMed ID: 6144047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of calcium channels in neuroblastoma x glioma hybrid cells by verapamil, D600, diltiazem and nisoldipine.
    Bodewei R; Hering S; Schubert B; Wollenberger A
    Biomed Biochim Acta; 1987; 46(8-9):S688-90. PubMed ID: 2449201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.
    Millard RW; Lathrop DA; Grupp G; Ashraf M; Grupp IL; Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):499-506. PubMed ID: 6277175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells.
    Lee KS; Tsien RW
    Nature; 1983 Apr; 302(5911):790-4. PubMed ID: 6302512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of different Ca2+ entry blockers on dopamine-induced inhibition of in vitro prolactin secretion.
    Di Renzo G; Amoroso S; Maida P; Canzoniero L; Nappi C; Taglialatela M; Annunzia L
    Eur J Pharmacol; 1988 Feb; 146(2-3):201-6. PubMed ID: 3371396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium blocking agents. New directions in the treatment of angina pectoris.
    Temkin LP
    Ariz Med; 1980 May; 37(5):328-33. PubMed ID: 6104480
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effects of verapamil, nicardipine and diltiazem on Ca2+-dependent and Ca2+-independent noradrenaline release and contraction in isolated canine saphenous veins.
    Takata Y; Kato H
    Pharmacology; 1988; 37(1):24-37. PubMed ID: 2458605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hemodynamic effects of calcium channel blocking agents: a brief review.
    Kieval J; Myerburg RJ
    Angiology; 1982 Aug; 33(8):516-21. PubMed ID: 6287888
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of calcium antagonist drugs on calcium currents in mammalian skeletal muscle fibers.
    Walsh KB; Bryant SH; Schwartz A
    J Pharmacol Exp Ther; 1986 Feb; 236(2):403-7. PubMed ID: 2418195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking actions of Ca2+ antagonists on the Ca2+ channels in the smooth muscle cell membrane of rabbit small intestine.
    Terada K; Kitamura K; Kuriyama H
    Pflugers Arch; 1987 May; 408(6):552-7. PubMed ID: 2439984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of diltiazem on human nicotinic acetylcholine and GABA(A) receptors.
    Houlihan LM; Slater EY; Beadle DJ; Lukas RJ; Bermudez I
    Neuropharmacology; 2000 Oct; 39(13):2533-42. PubMed ID: 11044725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockade in smooth muscle of the human upper urinary tract. I. Effects on depolarization-induced activation.
    Hertle L; Nawrath H
    J Urol; 1984 Dec; 132(6):1265-9. PubMed ID: 6094847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of multiple receptor sites within the putative calcium channel.
    Ferry DR; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):80-3. PubMed ID: 6292744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil and diltiazem inhibit receptor-operated calcium channels and intracellular calcium oscillations in rat hepatocytes.
    Striggow F; Bohnensack R
    FEBS Lett; 1993 Mar; 318(3):341-4. PubMed ID: 8382636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine potentiation of calcium ionophore, A-23187-induced platelet aggregation.
    Shah BH; Saeed SA; Rashid F; Gilani AH
    Adv Exp Med Biol; 1997; 407():537-40. PubMed ID: 9322004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.